Team and Network

Our People

Investment decisions in healthcare are only as good as the expertise that informs them.

Investment Team

Our investment team is responsible for the identification, evaluation, and structuring of each transaction. Their work is grounded in rigorous financial analysis, sector knowledge, and a governance framework designed to protect and create value at every stage.

Marco Fumagalli

Founding Partner

Stefano Alfonsi

Operating Partner

Carlo Sgarbi

Founding Partner

Marcello Nesta

Partner

Valentina de Paoli

Assistant

Valeria Giraldin

Administration Manager

Industry Experts

Alongside the investment team, VITA Continental Partners works with a select group of healthcare industry experts, professionals with hands-on experience across clinical, regulatory, and commercial functions. Their contribution ensures that the platform’s decisions are informed by genuine sector depth, not only financial logic.

Andrea Menghini

Senior Advisor

Elvio Gramignano

Senior Advisor

Russ Mably

Senior Advisor

Stefano Gallucci

Senior Advisor

Alexia Vagner

Senior Advisor

Angelo Bernasconi

Senior Advisor

Marco Fumagalli

Founding Partner

Marco Fumagalli has dedicated his entire career to private equity, with a sustained focus on the healthcare sector. He spent fourteen years as a Global Partner and CEO of the Italian Division at 3i Group, one of Europe’s leading private equity firms, where he managed investments in both private and publicly listed healthcare companies, including Vis Pharmaceuticals, Newron, and Novuspharma.

As the founder of Continental Investment Partners and a Partner at VITA Continental, Marco has active responsibility for new investments and portfolio management. 

Stefano Alfonsi

Operating Partner

Stefano Alfonsi has dedicated his entire career to leading MedTech companies at the highest level. He began at Johnson & Johnson/DePuy, where he rose to Worldwide Vice President of Marketing, before assuming a series of CEO mandates that have defined his standing in the industry. At LimaCorporate, he grew revenue from €50 million to €117 million. At Corin Group, he scaled the business from €50 million to €200 million over eight years through four strategic acquisitions. He subsequently served as CEO of Aleva Neurotherapeutics and, most recently, Elos Medtech, where he was appointed Chairman of the Board in 2021 before serving as President and CEO from 2022 to 2025.

As a Partner at VITA Continental, he focuses particularly on MedTech founders and management teams. 

Carlo Sgarbi

Founding Partner

Carlo Sgarbi spent more than 20 years in investment banking at Banca IMI, the investment banking arm of Intesa Sanpaolo Group, working across Global Markets, DCM, and M&A before becoming CEO and CIO of a major Swiss family office. During this period, he also founded a regulated asset management company and led a £55 million IPO on the London Stock Exchange’s AIM market. In 2013, he co-founded Continental Investment Partners with Marco Fumagalli.

As Managing Partner of Continental Investment Partners and a Partner at VITA Continental, Carlo leads investor relations and fundraising activities across the platform. 

Marcello Nesta

Partner

Marcello Nesta began his career at a corporate finance advisory firm, raising debt and equity capital for SMEs across a range of sectors. In 2017, he joined Continental Investment Partners as an Investment Manager. Since then, he has worked closely with portfolio companies, serving as CFO and a board member at RanD, AlfaMed, and Keros Digital, and as President of Happy Friends until its successful exit to Arcaplanet.

As a Partner at VITA Continental, Marcello leads new investments and portfolio management across the platform. 

Valentina de Paoli

Assistant

LinkedIn profile

Valentina has extensive experience in managing relationships with a broad range of counterparties. She has been part of Continental since 2017, where she handles administrative tasks. Within VITA Continental Partners, she plays a key role as an assistant to the entire team. 

Valeria Giraldin

Administration Manager

Valeria has more than 30 years of experience in accounting and administration across various European jurisdictions. Since 2013, she has served as Continental Investment Partners' Administration Manager. At VITA Continental, she oversees the administration and compliance of corporate structures. 

Andrea Menghini

Senior Advisor

Andrea has four decades of experience in the healthcare sector, having worked for multinational companies and grown and sold SMEs to both financial sponsors and industrial players. Throughout his career, he has gained experience across many specialisms, including cardiac surgery, blood management, spine, and oncology. 

Elvio Gramignano

Senior Advisor

Elvio Gramignano has built his career progressing from commercial roles to executive leadership, consultancy and entrepreneurship. He has worked across diagnostics, orthopaedics and other specialist MedTech sectors, gaining experience in both global multinationals and European innovation-led companies. Over the course of his career, he has developed deep expertise in commercial architecture, digital strategy, sales enablement for small and medium-sized medical device companies. Today, Elvio works as a consultant, entrepreneur and founder, helping growth-stage MedTech businesses build more structured, scalable and effective commercial systems. 

Russ Mably

Senior Advisor

Russ Mably has spent his entire career in the medical device industry, progressing from business development and commercial leadership roles to CEO-level positions in both multinational companies and growth-stage businesses. Throughout his career, he has developed deep expertise in orthopaedics, trauma, and life-saving medical technology, with significant experience in leading international commercial operations and driving growth through strategic acquisitions and market expansion. 

Stefano Gallucci

Senior Advisor

Stefano Gallucci has held several CEO mandates across industrial and deep-tech sectors, including electronics, industrial machinery, MedTech, and nanotechnology, leading multi-plant operations across Europe, Asia, and North America. A computer scientist and AI engineer by training, he has led buy-and-build strategies under both private equity and family ownership, completing three exits over the course of his career. He is also active as a board member and venture investor in deep-tech companies. 

Alexia Vagner

Senior Advisor

Alexia Vagner has built her career at the intersection of commercial strategy and the medical device industry, progressing through more than twenty years of increasingly senior sales and marketing roles within large healthcare companies. She has worked across medical devices and pharmaceuticals in both the French and international markets, developing deep expertise in strategic and operational marketing, medical marketing, market access, and communication. She now works as a consultant and founder, having established IDM+ to support medical device and healthcare companies — from startups to large corporations — in structuring and executing the commercialisation of their products in France. 

Angelo Bernasconi

Senior Advisor

Angelo Bernasconi has spent more than 30 years in the medical device industry, holding senior executive roles in multinational companies and innovative startups. A bioengineer by training, he served as Vice President of the Cardiac Rhythm Management Business Unit at LivaNova, where he led commercial strategy and strategic marketing across international markets. He subsequently joined Boston-based MyAir as Chief Commercial and Regulatory Officer, supporting the development of breath and sleep-apnoea monitoring systems. Today, he serves as CEO of SPS, a company developing innovative technologies for spinal surgery, and as Chairman of EP Solutions, which specialises in non-invasive cardiac mapping. He is also a board member of WISE, a MedTech company developing implantable leads for neuromonitoring and neuromodulation. Throughout his career, Angelo has developed extensive expertise in commercialising advanced medical devices and building international commercial organisations across Europe, the United States, Japan, and emerging markets.